MR-107A-02: Revolutionizing Non-Opioid Pain Man...

By Rene Pretorius

May 12, 2025

Viatris Inc.
Bulevirtide HDV Therapy: Promising Results in Durable Virologic Control
FDA AI Drug Approval
TAVR Asymptomatic Approval: A New Era for Early Intervention in Aortic Stenosis
Ivonescimab NMPA Approval Signals Breakthrough in Lung Cancer
ZEVASKYN Gene Therapy: A Breakthrough for Recessive Dystrophic Epidermolysis ...
Trodelvy Keytruda Combination Delivers Breakthrough Results in Metastatic Tri...
AI Pediatric Sarcoma Diagnosis: Improving Speed and Accuracy in Cancer Classi...
Urgent Need for Pediatric Heart Devices
Journavx for Pain Management: Toward Affordability and Access
FDA Approves Perioperative Immunotherapy for Bladder Cancer: A Breakthrough i...
Advancing Pediatric Leukemia Trial: Precision Medicine and Transformative Res...
Reserve Antibiotics Benefits: G-BA Designates Meropenem/Vaborbactam as Critic...